Richard S.E. Keefe NeuroCog Trials, Inc. Biography Publications Institution JoVE Articles Richard S.E. Keefe has not added a biography. If you are Richard S.E. Keefe and would like to personalize this page please email our Author Liaison for assistance. Publications Validation of the Persian Version of the Brief Assessment of Cognition in Schizophrenia in Patients with Schizophrenia and Healthy Controls Psychiatry and Clinical Neurosciences. Feb, 2014 | Pubmed ID: 24552637 Neuropsychological Decline in Schizophrenia from the Premorbid to the Postonset Period: Evidence from a Population-representative Longitudinal Study The American Journal of Psychiatry. Jan, 2014 | Pubmed ID: 24030246 The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR Perspective Schizophrenia Research. Dec, 2013 | Pubmed ID: 24139196 Unraveling the Relationship Between Obesity, Schizophrenia and Cognition Schizophrenia Research. Dec, 2013 | Pubmed ID: 24119725 Elevated Antisaccade Error Rate As an Intermediate Phenotype for Psychosis Across Diagnostic Categories Schizophrenia Bulletin. Sep, 2013 | Pubmed ID: 24080895 Preserved Working Memory and Altered Brain Activation in Persons at Risk for Psychosis The American Journal of Psychiatry. Nov, 2013 | Pubmed ID: 24077560 Microvascular Abnormality in Schizophrenia As Shown by Retinal Imaging The American Journal of Psychiatry. Dec, 2013 | Pubmed ID: 24030514 Issues and Perspectives in Designing Clinical Trials for Negative Symptoms in Schizophrenia Schizophrenia Research. Nov, 2013 | Pubmed ID: 24028744 Social Cognition As a Mediator Between Neurocognition and Functional Outcome in Individuals at Clinical High Risk for Psychosis Schizophrenia Research. Nov, 2013 | Pubmed ID: 24012459 Schizophrenia is a Cognitive Illness: Time for a Change in Focus JAMA Psychiatry. Oct, 2013 | Pubmed ID: 23925787 Brief Assessment of Cognition in Schizophrenia: Normative Data in an English-Speaking Ethnic Chinese Sample Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. Aug, 2013 | Pubmed ID: 23912998 Defining a Clinically Meaningful Effect for the Design and Interpretation of Randomized Controlled Trials Innovations in Clinical Neuroscience. May, 2013 | Pubmed ID: 23882433 Altered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis Schizophrenia Bulletin. Jul, 2013 | Pubmed ID: 23861539 Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study The American Journal of Psychiatry. Nov, 2013 | Pubmed ID: 23771174 Cognition in Schizophrenia: Summary Nice Consultation Meeting 2012 European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. Aug, 2013 | Pubmed ID: 23684476 Interview-based Assessment of Cognition in Schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in Different Phases of Illness and Settings of Care Schizophrenia Research. May, 2013 | Pubmed ID: 23510596 Applicability of the MATRICS Consensus Cognitive Battery in Singapore The Clinical Neuropsychologist. 2013 | Pubmed ID: 23362823 The Course of Cognitive Functioning over Six Months in Individuals at Clinical High Risk for Psychosis Psychiatry Research. Apr, 2013 | Pubmed ID: 23159196 Formulation of the Age-education Index: Measuring Age and Education Effects in Neuropsychological Performance Psychological Assessment. Mar, 2013 | Pubmed ID: 23148648 How Specific Are Negative Symptoms and Cognitive Impairment in Schizophrenia? An Analysis of PANSS and SCoRS Cognitive Neuropsychiatry. May, 2013 | Pubmed ID: 23145794 The Cognitive Assessment Interview (CAI): Reliability and Validity of a Brief Interview-based Measure of Cognition Schizophrenia Bulletin. May, 2013 | Pubmed ID: 22328641 Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data Schizophrenia Bulletin. May, 2013 | Pubmed ID: 22290266 Clinical Trials of Potential Cognitive-enhancing Drugs in Schizophrenia: What Have We Learned So Far? Schizophrenia Bulletin. Mar, 2013 | Pubmed ID: 22114098 Standardizing the Use of the Continuous Performance Test in Schizophrenia Research: a Validation Study Schizophrenia Research. Dec, 2012 | Pubmed ID: 23040735 Cognitive Impairment in Schizophrenia Handbook of Experimental Pharmacology. 2012 | Pubmed ID: 23027411 Persistent Cannabis Users Show Neuropsychological Decline from Childhood to Midlife Proceedings of the National Academy of Sciences of the United States of America. Oct, 2012 | Pubmed ID: 22927402 Validation of a Clinician Questionnaire to Assess Reasons for Antipsychotic Discontinuation and Continuation Among Patients with Schizophrenia Psychiatry Research. Dec, 2012 | Pubmed ID: 22841345 Feasibility and Pilot Efficacy Results from the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial The Journal of Clinical Psychiatry. Jul, 2012 | Pubmed ID: 22687548 A Randomized Controlled Trial of Allopurinol Vs. Placebo Added on to Antipsychotics in Patients with Schizophrenia or Schizoaffective Disorder Schizophrenia Research. Jun, 2012 | Pubmed ID: 22483162 Clues to the Cognitive and Perceptual Origins of Social Isolation and Psychosis in Schizophrenia The American Journal of Psychiatry. Apr, 2012 | Pubmed ID: 22476674 Effect of the Neuroprotective Peptide Davunetide (AL-108) on Cognition and Functional Capacity in Schizophrenia Schizophrenia Research. Apr, 2012 | Pubmed ID: 22169248 The Singapore Flagship Programme in Translational and Clinical Research in Psychosis Early Intervention in Psychiatry. Nov, 2011 | Pubmed ID: 22032547 Substance Use and Schizophrenia: Adverse Correlates in the CATIE Study Sample Schizophrenia Research. Nov, 2011 | Pubmed ID: 21872443 Cognitive Effects of Atypical Antipsychotic Medications in Patients with Alzheimer's Disease: Outcomes from CATIE-AD The American Journal of Psychiatry. Aug, 2011 | Pubmed ID: 21572163 Longitudinal Consent-related Abilities Among Research Participants with Schizophrenia: Results from the CATIE Study Schizophrenia Research. Aug, 2011 | Pubmed ID: 21561740 Comprehensive Model of How Reality Distortion and Symptoms Occur in Schizophrenia: Could Impairment in Learning-dependent Predictive Perception Account for the Manifestations of Schizophrenia? Psychiatry and Clinical Neurosciences. Jun, 2011 | Pubmed ID: 21447049 Bifactor and Item Response Theory Analyses of Interviewer Report Scales of Cognitive Impairment in Schizophrenia Psychological Assessment. Mar, 2011 | Pubmed ID: 21381848 Performance and Interview-based Assessments of Cognitive Change in a Randomized, Double-blind Comparison of Lurasidone Vs. Ziprasidone Schizophrenia Research. Apr, 2011 | Pubmed ID: 21277745 Methodological Issues in Negative Symptom Trials Schizophrenia Bulletin. Mar, 2011 | Pubmed ID: 21270473 The MCCB Impairment Profile for Schizophrenia Outpatients: Results from the MATRICS Psychometric and Standardization Study Schizophrenia Research. Mar, 2011 | Pubmed ID: 21159492 A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with Schizophrenia Biological Psychiatry. Mar, 2011 | Pubmed ID: 21145041 Failures in Learning-dependent Predictive Perception As the Key Cognitive Vulnerability to Psychosis in Schizophrenia Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Jan, 2011 | Pubmed ID: 21116261 Criminal Justice System Involvement Among People with Schizophrenia Community Mental Health Journal. Dec, 2011 | Pubmed ID: 21113799 Genome-wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Feb, 2011 | Pubmed ID: 21107309 Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site Antipsychotic Schizophrenia Clinical Trial Schizophrenia Research. Feb, 2011 | Pubmed ID: 21075600 Treatment Outcomes of Patients with Tardive Dyskinesia and Chronic Schizophrenia The Journal of Clinical Psychiatry. Mar, 2011 | Pubmed ID: 20816031 The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-enhancing Drugs: What Do We Know 5 Years Later? Schizophrenia Bulletin. Nov, 2011 | Pubmed ID: 20410237 Report from the Working Group Conference on Multisite Trial Design for Cognitive Remediation in Schizophrenia Schizophrenia Bulletin. Sep, 2011 | Pubmed ID: 20194249 A Brief Cognitive Assessment Tool for Schizophrenia: Construction of a Tool for Clinicians Schizophrenia Bulletin. May, 2011 | Pubmed ID: 19776205 Differential Effects of Emotional Information on Interference Task Performance Across the Life Span Frontiers in Aging Neuroscience. 2010 | Pubmed ID: 20953250 Armodafinil As Adjunctive Therapy in Adults with Cognitive Deficits Associated with Schizophrenia: a 4-week, Double-blind, Placebo-controlled Study The Journal of Clinical Psychiatry. Nov, 2010 | Pubmed ID: 20816042 The Cognitive Assessment Interview (CAI): Development and Validation of an Empirically Derived, Brief Interview-based Measure of Cognition Schizophrenia Research. Aug, 2010 | Pubmed ID: 20542412 Neuropsychology of the Prodrome to Psychosis in the NAPLS Consortium: Relationship to Family History and Conversion to Psychosis Archives of General Psychiatry. Jun, 2010 | Pubmed ID: 20530007 No Association of the Serotonin Transporter Polymorphisms 5-HTTLPR and RS25531 with Schizophrenia or Neurocognition American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. Jul, 2010 | Pubmed ID: 20468059 The Schizophrenia Cognition Rating Scale: Validation of an Interview-based Assessment of Cognitive Functioning in Asian Patients with Schizophrenia Psychiatry Research. Jun, 2010 | Pubmed ID: 20451258 Etiological and Clinical Features of Childhood Psychotic Symptoms: Results from a Birth Cohort Archives of General Psychiatry. Apr, 2010 | Pubmed ID: 20368509 Circumstances Under Which Practice Does Not Make Perfect: a Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Apr, 2010 | Pubmed ID: 20090669 Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: a 30-year Study The American Journal of Psychiatry. Feb, 2010 | Pubmed ID: 20048021 Anticipating DSM-V: Opportunities and Challenges for Cognition and Psychosis Schizophrenia Bulletin. Jan, 2010 | Pubmed ID: 19923191 The Effects of Antipsychotic Medications on Emotion Perception in Patients with Chronic Schizophrenia in the CATIE Trial Schizophrenia Research. Nov, 2009 | Pubmed ID: 19766459 Memory-prediction Errors and Their Consequences in Schizophrenia Neuropsychology Review. Sep, 2009 | Pubmed ID: 19575296 Measuring Memory-prediction Errors and Their Consequences in Youth at Risk for Schizophrenia Annals of the Academy of Medicine, Singapore. May, 2009 | Pubmed ID: 19521641 Psychosocial Factors in the Neurobiology of Schizophrenia: a Selective Review Annals of the Academy of Medicine, Singapore. May, 2009 | Pubmed ID: 19521639 Proof-of-concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Jul, 2009 | Pubmed ID: 19339966 A Genome-wide Investigation of SNPs and CNVs in Schizophrenia PLoS Genetics. Feb, 2009 | Pubmed ID: 19197363 Pharmacogenetics of Antipsychotic Response in the CATIE Trial: a Candidate Gene Analysis European Journal of Human Genetics : EJHG. Jul, 2009 | Pubmed ID: 19156168 Results of Phase 3 of the CATIE Schizophrenia Trial Schizophrenia Research. Jan, 2009 | Pubmed ID: 19027269 CMINDS Does Not Have Identical Tests to the CATIE and MATRICS Batteries. Commentary on O'Halloran Et Al Schizophrenia Research. Feb, 2009 | Pubmed ID: 19013770 Development and Psychometric Performance of the Schizophrenia Objective Functioning Instrument: an Interviewer Administered Measure of Function Schizophrenia Research. Feb, 2009 | Pubmed ID: 19013769 Abbreviated Neuropsychological Assessment in Schizophrenia: Prediction of Different Aspects of Outcome Journal of Clinical and Experimental Neuropsychology. May, 2009 | Pubmed ID: 18720182 Cognition and Schizophrenia: is There a Role for Cognitive Assessments in Diagnosis and Treatment? Psychiatry (Edgmont (Pa. : Township)). Dec, 2008 | Pubmed ID: 19724777 Extrapyramidal Side-effects of Antipsychotics in a Randomised Trial The British Journal of Psychiatry : the Journal of Mental Science. Oct, 2008 | Pubmed ID: 18827289 Neuropsychological Course in the Prodrome and First Episode of Psychosis: Findings from the PRIME North America Double Blind Treatment Study Schizophrenia Research. Oct, 2008 | Pubmed ID: 18774696 Implementation Considerations for Multisite Clinical Trials with Cognitive Neuroscience Tasks Schizophrenia Bulletin. Jul, 2008 | Pubmed ID: 18495645 Norms and Standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) Schizophrenia Research. Jul, 2008 | Pubmed ID: 18495435 Should Cognitive Impairment Be Included in the Diagnostic Criteria for Schizophrenia? World Psychiatry : Official Journal of the World Psychiatric Association (WPA). Feb, 2008 | Pubmed ID: 18458774 What CATIE Found: Results from the Schizophrenia Trial Psychiatric Services (Washington, D.C.). May, 2008 | Pubmed ID: 18451005 Relationship of Cognition and Psychopathology to Functional Impairment in Schizophrenia The American Journal of Psychiatry. Aug, 2008 | Pubmed ID: 18450928 The Neuregulin 1 Promoter Polymorphism Rs6994992 is Not Associated with Chronic Schizophrenia or Neurocognition American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. Oct, 2008 | Pubmed ID: 18286587 Efficiency of the CATIE and BACS Neuropsychological Batteries in Assessing Cognitive Effects of Antipsychotic Treatments in Schizophrenia Journal of the International Neuropsychological Society : JINS. Mar, 2008 | Pubmed ID: 18282319 Employment Outcomes in a Randomized Trial of Second-generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia The Journal of Behavioral Health Services & Research. Apr, 2008 | Pubmed ID: 18246429 The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity The American Journal of Psychiatry. Feb, 2008 | Pubmed ID: 18172019 The MATRICS Consensus Cognitive Battery, Part 2: Co-norming and Standardization The American Journal of Psychiatry. Feb, 2008 | Pubmed ID: 18172018 Functional Co-primary Measures for Clinical Trials in Schizophrenia: Results from the MATRICS Psychometric and Standardization Study The American Journal of Psychiatry. Feb, 2008 | Pubmed ID: 18172017 Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/practice Effects in a 12-week, Randomized, Double-blind, Placebo-controlled Trial Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. May, 2008 | Pubmed ID: 17625502 Cognitive Deficits in Patients with Schizophrenia: Effects and Treatment The Journal of Clinical Psychiatry. 2007 | Pubmed ID: 18284272 Cognition As an Outcome Measure in Schizophrenia The British Journal of Psychiatry. Supplement. Aug, 2007 | Pubmed ID: 18019044 Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: a Randomized, Double-blind 52-week Comparison The American Journal of Psychiatry. Jul, 2007 | Pubmed ID: 17606658 How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment? Schizophrenia Bulletin. Jul, 2007 | Pubmed ID: 17567627 Neurocognitive Effects of Antipsychotic Medications in Patients with Chronic Schizophrenia in the CATIE Trial Archives of General Psychiatry. Jun, 2007 | Pubmed ID: 17548746 AKT1 and Neurocognition in Schizophrenia The Australian and New Zealand Journal of Psychiatry. Feb, 2007 | Pubmed ID: 17464696 Validation of the French Version of the BACS (the Brief Assessment of Cognition in Schizophrenia) Among 50 French Schizophrenic Patients European Psychiatry : the Journal of the Association of European Psychiatrists. Sep, 2007 | Pubmed ID: 17434715 Effects of Antipsychotic Medications on Psychosocial Functioning in Patients with Chronic Schizophrenia: Findings from the NIMH CATIE Study The American Journal of Psychiatry. Mar, 2007 | Pubmed ID: 17329467 Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients with Chronic Schizophrenia After Discontinuing Perphenazine: a CATIE Study The American Journal of Psychiatry. Mar, 2007 | Pubmed ID: 17329466 Risperidone and Cognitive Function in Children with Disruptive Behavior Disorders Biological Psychiatry. Aug, 2007 | Pubmed ID: 17210137 NCAM1 and Neurocognition in Schizophrenia Biological Psychiatry. Apr, 2007 | Pubmed ID: 17161382 Missing the Sweet Spot Disengagement in Schizophrenia Psychiatry (Edgmont (Pa. : Township)). Jul, 2006 | Pubmed ID: 20975816 Cost-effectiveness of Second-generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia The American Journal of Psychiatry. Dec, 2006 | Pubmed ID: 17151158 A Longitudinal Study of Neurocognitive Function in Individuals At-risk for Psychosis Schizophrenia Research. Dec, 2006 | Pubmed ID: 16930949 Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial Psychiatric Services (Washington, D.C.). Aug, 2006 | Pubmed ID: 16870959 Insight in First-episode Psychosis Psychological Medicine. Oct, 2006 | Pubmed ID: 16740175 Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Sep, 2006 | Pubmed ID: 16641947 Optimization of a Multinomial Model for Investigating Hallucinations and Delusions with Source Monitoring Schizophrenia Research. Jul, 2006 | Pubmed ID: 16626938 Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients with Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic The American Journal of Psychiatry. Apr, 2006 | Pubmed ID: 16585435 Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients with Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment The American Journal of Psychiatry. Apr, 2006 | Pubmed ID: 16585434 The Schizophrenia Cognition Rating Scale: an Interview-based Assessment and Its Relationship to Cognition, Real-world Functioning, and Functional Capacity The American Journal of Psychiatry. Mar, 2006 | Pubmed ID: 16513863 The Relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to Functional Capacity and Real-world Functional Outcome Journal of Clinical and Experimental Neuropsychology. Feb, 2006 | Pubmed ID: 16484097 One-year Double-blind Study of the Neurocognitive Efficacy of Olanzapine, Risperidone, and Haloperidol in Schizophrenia Schizophrenia Research. Jan, 2006 | Pubmed ID: 16202565 Long-term Neurocognitive Effects of Olanzapine or Low-dose Haloperidol in First-episode Psychosis Biological Psychiatry. Jan, 2006 | Pubmed ID: 16140282 Measuring Outcome Priorities and Preferences in People with Schizophrenia The British Journal of Psychiatry : the Journal of Mental Science. Dec, 2005 | Pubmed ID: 16319405 Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia The New England Journal of Medicine. Sep, 2005 | Pubmed ID: 16172203 Clinical Correlates of Tardive Dyskinesia in Schizophrenia: Baseline Data from the CATIE Schizophrenia Trial Schizophrenia Research. Dec, 2005 | Pubmed ID: 16171976 The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical Comparison of Subgroups with and Without the Metabolic Syndrome Schizophrenia Research. Dec, 2005 | Pubmed ID: 16125372 A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia Schizophrenia Bulletin. Jan, 2005 | Pubmed ID: 15888422 Antipsychotic Drug Effects on Brain Morphology in First-episode Psychosis Archives of General Psychiatry. Apr, 2005 | Pubmed ID: 15809403 Defining a Cognitive Function Decrement in Schizophrenia Biological Psychiatry. Mar, 2005 | Pubmed ID: 15780858 Approaching a Consensus Cognitive Battery for Clinical Trials in Schizophrenia: the NIMH-MATRICS Conference to Select Cognitive Domains and Test Criteria Biological Psychiatry. Sep, 2004 | Pubmed ID: 15336511 Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-episode Psychosis: a Randomized, Double-blind Trial of Olanzapine Versus Low Doses of Haloperidol The American Journal of Psychiatry. Jun, 2004 | Pubmed ID: 15169686 The Brief Assessment of Cognition in Schizophrenia: Reliability, Sensitivity, and Comparison with a Standard Neurocognitive Battery Schizophrenia Research. Jun, 2004 | Pubmed ID: 15099610 Cognitive Functioning in Schizophrenia: a Consensus Statement on Its Role in the Definition and Evaluation of Effective Treatments for the Illness The Journal of Clinical Psychiatry. Mar, 2004 | Pubmed ID: 15096076 Neurocognitive Assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project Schizophrenia Trial: Development, Methodology, and Rationale Schizophrenia Bulletin. 2003 | Pubmed ID: 12908660 Source Monitoring Improvement in Patients with Schizophrenia Receiving Antipsychotic Medications Psychopharmacology. Sep, 2003 | Pubmed ID: 12759802 Source-monitoring Deficits for Self-generated Stimuli in Schizophrenia: Multinomial Modeling of Data from Three Sources Schizophrenia Research. Sep, 2002 | Pubmed ID: 12165376 Sensory Acuity and Reasoning in Delusional Disorder Comprehensive Psychiatry. May-Jun, 2002 | Pubmed ID: 11994833 रोजमर्रा के जीवन कौशल का एक आभासी वास्तविकता आकलन का विकास Stacy A. Ruse1, Vicki G. Davis1, Alexandra S. Atkins1, K. Ranga R. Krishnan2,3, Kolleen H. Fox4, Philip D. Harvey5, Richard S.E. Keefe1,3 1NeuroCog Trials, Inc., 2Duke-NUS Graduate Medical Center, 3Duke University Medical Center, 4Fox Evaluation and Consulting, PLLC, 5University of Miami Miller School of Medicine JoVE 51405 Comportamento
रोजमर्रा के जीवन कौशल का एक आभासी वास्तविकता आकलन का विकास Stacy A. Ruse1, Vicki G. Davis1, Alexandra S. Atkins1, K. Ranga R. Krishnan2,3, Kolleen H. Fox4, Philip D. Harvey5, Richard S.E. Keefe1,3 1NeuroCog Trials, Inc., 2Duke-NUS Graduate Medical Center, 3Duke University Medical Center, 4Fox Evaluation and Consulting, PLLC, 5University of Miami Miller School of Medicine JoVE 51405 Comportamento